Pattern of Infliximab Biosimilars Uptake in US Reveals Ongoing Concerns

Rheumatoid Arthritis News

Pattern of Infliximab Biosimilars Uptake in US Reveals Ongoing Concerns
RA - Rheumatoid ArthritisRheumatoid Arthritis (RA)Biologic Therapy
  • 📰 Medscape
  • ⏱ Reading Time:
  • 36 sec. here
  • 22 min. at publisher
  • 📊 Quality Score:
  • News: 88%
  • Publisher: 55%

Use of infliximab biosimilars in the United States rose slowly until three were on the market; it continued to remain low for Medicare than for Medicaid and private insurance beneficiaries in 2022.

biosimilars rose slowly across private insurance, Medicaid, and Medicare when two were available in the United States during 2016-2020 but increased significantly through 2022 after the third biosimilar became available in July 2020. However, prescriptions in Medicare still lagged behind those in private insurance and Medicaid.

They conducted an interrupted time series to account for autocorrelation and model the effect of each infliximab biosimilar release on uptake across Medicare, Medicaid, and private insurers.The researchers identified 659,988 infliximab administrations for 37,560 unique patients, with 52% on Medicare, 4.8% on Medicaid, and 43% on private insurance.After the third biosimilar release in July 2020, the average annual increase reached 13% for Medicaid and 16.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.Anti-Vax Doctor Simone Gold Sued by America's Frontline Doctors, the Group She Founded

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

RA - Rheumatoid Arthritis Rheumatoid Arthritis (RA) Biologic Therapy Biologics Psoriatic Arthritis Arthropathic Psoriasis Psoriatic Arthropathy Psa Inflammatory Bowel Disease IBD - Inflammatory Bowel Disease IBD Crohn's Disease Crohn Disease Regional Enteritis Crohn Crohn’S Ulcerative Colitis Ulcerative Colitis (UC) UC - Ulcerative Colitis Psoriasis

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Two Soliris Biosimilar Approved for PNH in the United StatesTwo Soliris Biosimilar Approved for PNH in the United StatesThe biosimilars, Bkemv and Epysqli, are also indicated for atypical hemolytic uremic syndrome.
Read more »

Study reveals historical mismatch in Southern Ocean contributes to heat and carbon uptakeStudy reveals historical mismatch in Southern Ocean contributes to heat and carbon uptakeThe Southern Ocean plays a central role in the global uptake of heat and carbon, which is widely thought to be due to its unique upwelling and circulation. An international research team, led by the University of Liverpool, explored whether there are differences in how the Southern Ocean contributes to the global uptake of heat and carbon.
Read more »

Unraveling how potassium bound to soil minerals is made bioavailable for uptake by plantsUnraveling how potassium bound to soil minerals is made bioavailable for uptake by plantsA combination of X-ray absorption spectroscopy and computational methods has revealed the unique bonding environment of potassium associated with organic acids.
Read more »

Vehicle to Grid: Changes Down Under Ease UptakeVehicle to Grid: Changes Down Under Ease UptakeAustralia is moving rapidly to accomodate the uptake of EV's as batteries on wheels by rewritng the regulations concerning vehicle to grid.
Read more »

Philanthropy's Blockchain Uptake Is Slow, But Future Is BrightPhilanthropy's Blockchain Uptake Is Slow, But Future Is BrightPaul Brody is Global Blockchain Leader for EY (Ernst & Young). Under his leadership, EY is established a global presence in the blockchain space with a particular focus on public blockchains, assurance, and business application development in the Ethereum ecosystem.
Read more »

Solar & Wind Uptake to Reach 5.4 TWac from 2024 to 2033Solar & Wind Uptake to Reach 5.4 TWac from 2024 to 2033Solar and wind uptake to reach 5.4 TWac from 2024 to 2033 wood machenzie research on solar and wind with graphs
Read more »



Render Time: 2025-02-15 06:47:39